Orphan Drugs Market 2015-2019 Industry Key Trends, Size, Growth, Shares and Forecast Research Report

Researchmoz added Most up-to-date research on "Orphan Drugs Market 2015-2019" to its huge collection of research reports.

An orphan drug is used to treat rare diseases or disorders. According to WHO, orphan or rare diseases are the pathological conditions that affect 0.65-1 out of 10,000 population worldwide. There are around 6,000 orphan diseases, of which 80% are genetic. Orphan drugs are developed by the pharmaceutical industry to serve the public health need. These are designated as "Orphan Designations" by the regulatory agencies to accelerate the approval process.

Market analysts forecast the global orphan drugs market to grow at a CAGR of 10.05% over the period 2014-2019.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=459127

Covered in this report

The report covers the current scenario and the growth prospects of the global orphan drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales orphan drugs.

New report, Global Orphan Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global orphan drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

Americas

APAC

Europe

Key vendors

Bristol-Mayer Squibb

Celgene

F. Hoffmann La Roche

Novartis

Pfizer

Other prominent vendors

AbbVie

Actelion Pharmaceuticals

Alexion Pharmaceuticals

Alnylam Pharmaceuticals

Amgen

AstraZeneca

Baxter International

Biogen Idec

Celldex Therapeutics

Eisai

Eli Lilly

GlaxoSmithKline

Intercept Pharmaceuticals

Johnson & Johnson

Merck

NewLink Genetics

Northwest Biotherapeutics

Novo Nordisk

Onyx Pharmaceuticals

Sanofi

Shire

Synageva BioPharma

Takeda

Vertex Pharmaceuticals

XOMA

Market driver...